Post-FDA Approval Results of Epithelium-Off, Full-Fluence, Dresden Protocol Corneal Collagen Crosslinking in the USA
Sign Up to like & getrecommendations! Published in 2020 at "Ophthalmology and Therapy"
DOI: 10.1007/s40123-020-00306-1
Abstract: The purpose of this non-comparative, prospective, observational study was to evaluate the post-US Food and Drug Administration approval outcomes of epithelium-off, full-fluence, Dresden protocol corneal collagen crosslinking (CXL) for the treatment of progressive keratoconus (KCN)… read more here.
Keywords: corneal; dresden protocol; full fluence; epithelium full ... See more keywords